When do you consider incorporating an antihistamine into the treatment of patients with long COVID–related neuropsychiatric symptoms?  

Is there a role for the use of antihistamines to treat neuropsychiatric symptoms of long COVID? Which neuropsychiatric symptoms (e.g., brain fog, fatigue, or anxiety) have you found most responsive to antihistamine treatment? Do you favor specific agents or dosing strategies?